BNP PARIBAS ARBITRAGE/PUT/DIASORIN/90/0.1/19.12.24

BNP PARIBAS ARBITRAGE/PUT/DIASORIN/90/0.1/19.12.24 Share Price

P206K7

NLBNPIT206K7

Market Closed - Borsa Italiana 01:35:00 01/06/2024 am IST
0.484 ^EUR	+5.45%

1 month

-30.58%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Chart BNP PARIBAS ARBITRAGE/PUT/DIASORIN/90/0.1/19.12.24

Latest news about DIASORIN S.P.A.

Funds move on Banco BPM, DiaSorin and Webuild.	30/05	AN
Futures bearish; focus on European data	30/05	AN
Stock markets in the red; DiaSorin snap on Mib.	29/05	AN
Indices flat; Newlat runs after Princes acquisition.	27/05	AN

More news

Quotes 5-day view

Date	Price	Change
31/24/31	0.495	+7.84%
30/24/30	0.459	+0.44%
29/24/29	0.457	-9.86%
28/24/28	0.507	+0.80%
27/24/27	0.503	-3.45%

Real-time Borsa Italiana

Last update May 01, 2024 at 01:35 am IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P206K7
ISIN	NLBNPIT206K7
Date issued	01/03/2024
Strike	90 €
Maturity	19/12/2024 (200 Days)
Parity	10 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.262 €
Lowest since issue	0.41 €
Spread	0.15 €
Spread %	26.83%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

98.94 EUR

Average target price

100.1 EUR

Spread / Average Target

+1.15%

Consensus